These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39011654)

  • 41. Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma.
    Zhang S; Tuo P; Ji Y; Huang Z; Xiong Z; Li H; Ruan C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):310. PubMed ID: 38890166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
    Saito Y; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
    Oncol Rep; 2010 May; 23(5):1325-30. PubMed ID: 20372847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic Analysis of Circulating Extracellular Vesicles Identifies Potential Biomarkers for Lymph Node Metastasis in Oral Tongue Squamous Cell Carcinoma.
    Qu X; Leung TCN; Ngai SM; Tsai SN; Thakur A; Li WK; Lee Y; Leung L; Ng TH; Yam J; Lan L; Lau EHL; Wong EWY; Chan JYK; Meehan K
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Capturing and identification of differentially expressed fucome by a gel free and label free approach.
    Puangpila C; El Rassi Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():112-21. PubMed ID: 25817263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies.
    Wang M; Tsai TH; Di Poto C; Ferrarini A; Yu G; Ressom HW
    BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):545. PubMed ID: 27535232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
    Megger DA; Bracht T; Kohl M; Ahrens M; Naboulsi W; Weber F; Hoffmann AC; Stephan C; Kuhlmann K; Eisenacher M; Schlaak JF; Baba HA; Meyer HE; Sitek B
    Mol Cell Proteomics; 2013 Jul; 12(7):2006-20. PubMed ID: 23462207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone.
    Gidlöf O; Evander M; Rezeli M; Marko-Varga G; Laurell T; Erlinge D
    Sci Rep; 2019 Jun; 9(1):8991. PubMed ID: 31222168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
    Kim KH; Kim JY; Yoo JS
    Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
    Cui J; Kang X; Dai Z; Huang C; Zhou H; Guo K; Li Y; Zhang Y; Sun R; Chen J; Li Y; Tang Z; Uemura T; Liu Y
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):825-34. PubMed ID: 17516088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
    Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H
    Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
    J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic Analysis of Plasma-Derived Extracellular Vesicles From Mice With
    Shi C; Zhou X; Yang W; Wu J; Bai M; Zhang Y; Zhao W; Yang H; Nagai A; Yin M; Gao X; Ding S; Zhao J
    Front Cell Infect Microbiol; 2022; 12():805010. PubMed ID: 35360110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
    Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
    Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced peptide quantification using spectral count clustering and cluster abundance.
    Lee S; Kwon MS; Lee HJ; Paik YK; Tang H; Lee JK; Park T
    BMC Bioinformatics; 2011 Oct; 12():423. PubMed ID: 22034872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis.
    Li H; Rong Z; Wang H; Zhang N; Pu C; Zhao Y; Zheng X; Lei C; Liu Y; Luo X; Chen J; Wang F; Wang A; Wang J
    Biol Sex Differ; 2020 Aug; 11(1):46. PubMed ID: 32792008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
    Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
    J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.